Nighttime itch can be annoying and even worrying. Here, 5 possible reasons you're itchy at night, as well as ...

Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...

Tharimmune, Inc. (NASDAQ:THAR) shares are moving higher Wednesday after the company announced it received overall positive ...

Having an itch that you just can’t scratch is one of the most frustrating experiences – but it might actually be beneficial ...

Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Tharimmune (THAR) received feedback from a Scientific Advice meeting with the European Medicines Agency that included guidance on a planned ...

2 Common symptoms like fatigue and pruritus (chronic itch) are sometimes misdiagnosed as conditions like atopic dermatitis or psoriasis, causing delays in diagnosis and suitable treatment.

A recent literature review presents a range of causes and treatments for chronic pruritus, including more novel options and a disease schematic for clinical decision support. The review has been ...

Real-time index price for TSX Oil and Gas EW Index (TXOE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

TH104, the Company's lead candidate for moderate-to-severe pruritus in chronic liver disease, showed no opioid withdrawal ...

In the three aforementioned studies of epidural delivery of naloxone in combination with an opioid (fentanyl or morphine), the frequency of pruritus was decreased, with no reversal of analgesia noted.